Resources
Psilocybin News is a news and education publication, not a medical provider. The resources below are the primary sources our editors rely on — peer-reviewed research, official trial registries, regulators and support services.
Find a clinical trial
- ClinicalTrials.gov — psilocybin studies — the official US registry of recruiting and ongoing trials.
- uAspire Phase 3 trial (NCT06308653) — psilocybin for major depressive disorder.
Peer-reviewed research
- PubMed — psilocybin literature — the US National Library of Medicine index of biomedical research.
- Living systematic review of psilocybin for depression — Nature Mental Health's continuously updated evidence database.
- JAMA: What Is Psilocybin? — a clinical overview for patients and clinicians.
Regulators and policy
- FDA — Psychedelic Drugs — official guidance and news on psychedelic drug development.
- Oregon Psilocybin Services — the first state-licensed psilocybin program.
If you need help now
- 988 Suicide & Crisis Lifeline — call or text 988 (US), free and confidential, 24/7.
- Crisis Text Line — text HOME to 741741.
Nothing on this page is medical or legal advice. Always talk to a qualified clinician about your own situation.
